Norelgestromin
- Generic Name
- Norelgestromin
- Brand Names
- Evra, Xulane, Zafemy
- Drug Type
- Small Molecule
- Chemical Formula
- C21H29NO2
- CAS Number
- 53016-31-2
- Unique Ingredient Identifier
- R0TAY3X631
Overview
Norelgestromin is a drug used in contraception. Norelgestromin is the active progestin responsible for the progestational activity that occurs in women after application of ORTHO EVRA patch.
Background
Norelgestromin is a drug used in contraception. Norelgestromin is the active progestin responsible for the progestational activity that occurs in women after application of ORTHO EVRA patch.
Indication
Norelgestromin is used for contraception and menopausal hormonal therapy. Norelgestromin may potentially be used in breast cancer treatment due to its inhibitory effect on estrone sulfatase . They convert sulfated steroid precursors to estrogen during pregnancy.
Associated Conditions
- Polycystic Ovarian Syndrome (PCOS)
Clinical Trials
FDA Approved Products
norelgestromin and ethinyl estradiol
Manufacturer:Zydus Lifesciences Limited
Route:TRANSDERMAL
Strength:150 ug in 1 mg
Approved: 2023/09/16
NDC:70771-1777
ZAFEMY
Manufacturer:Bryant Ranch Prepack
Route:TRANSDERMAL
Strength:150 ug in 1 d
Approved: 2024/01/05
NDC:72162-2220
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath